SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Oliver & Co who wrote (5003)7/26/1998 6:15:00 PM
From: Oliver & Co   of 6136
 
This is what I found so far, three studies, but I can not access the Abstracts yet.
======================================================================

2786-2805 Tripeptide Aldehyde Inhibitors of Human Rhinovirus 3C Protease: Design, Synthesis, Biological Evaluation, and Cocrystal Structure Solution of P1 Glutamine Isosteric Replacements Stephen E. Webber, Koji Okano, Thomas L. Little, Siegfried H. Reich, Yue Xin, Shella A. Fuhrman, David A. Matthews, Robert A. Love, Thomas F. Hendrickson, Amy K. Patick, James W. Meador, III, Rose Ann Ferre, Edward L. Brown, Clifford E. Ford, Susan L. Binford, and Stephen T. Worland [Abstract][Full Text - HTML][Full Text - PDF][Purchase Article]

2806-2818 Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 1. Michael Acceptor Structure-Activity Studies Peter S. Dragovich, Stephen E. Webber, Robert E. Babine, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Caroline A. Lee, Siegfried H. Reich, Thomas J. Prins, Joseph T. Marakovits, Ethel S. Littlefield, Ru Zhou, Jayashree Tikhe, Clifford E. Ford, Michael B. Wallace, James W. Meador, III, Rose Ann Ferre, Edward L. Brown, Susan L. Binford, James E. V. Harr, Dorothy M. DeLisle, and Stephen T. Worland [Abstract][Full Text - HTML][Full Text - PDF][Purchase Article]

2819-2834 Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 2. Peptide Structure-Activity Studies Peter S. Dragovich, Stephen E. Webber, Robert E. Babine, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Siegfried H. Reich, Joseph T. Marakovits, Thomas J. Prins, Ru Zhou, Jayashree Tikhe, Ethel S. Littlefield, Ted M. Bleckman, Michael B. Wallace, Thomas L. Little, Clifford E. Ford, James W. Meador, III, Rose Ann Ferre, Edward L. Brown, Susan L. Binford, Dorothy M. DeLisle, and Stephen T. Worland [Abstract][Full Text - HTML][Full Text - PDF][Purchase Article]
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext